亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Ultra-low Power, Wireless Implantable Neural Electrode System

标题
Neural Interface Systems and Methods
详细技术说明
None
*Abstract

Interfaces with Neural Tissue for Recording and Stimulation

This implantable neural electrode device serves as a potential therapy for patients suffering from a host of neurological disorders in the central or peripheral nervous system. According to a report by the World Health Organization, neurological disorders ranging from migraines to epilepsy and dementia, affect up to one billion people worldwide, and that number is expected to rise as populations age. Researchers at the University of Florida have developed a device that far surpasses any available therapy because it enables unprecedented miniaturization and minimal power consumption. This wireless, implantable system increases health safety and convenience compared to existing external, bulky devices.

Applications

A technology in neuroprosthetics that serves as a potential therapy for patients suffering from a host of neurological disorders in the central or peripheral nervous system

Advantages

  • Ability to be implanted under the skin, minimizing the risk of infection
  • Increases mobility and convenience due to light weight and wireless capability
  • Uses signal compression, which provides for long battery life and the ability to be recharged
  • Capability of all components to be hybrid integrated on the same micro-machined substrate, minimizing fabrication costs
  • Provides greater reliability and accuracy in signal recognition for longer periods of time, making it the most effective therapy available and providing a unique competitive advantage

Technology

This fully-integrated, implantable neural electrode system has low power consumption. The system utilizes an interface with neural tissue for recording, as well as stimulating, neural activity in a research subject or patient. With the use of the flexible substrate as a hybrid platform to integrate the electrodes, the amplification and signal processing electronics, and the wireless transmission and power management electronics, this therapy far surpasses anything currently available. The electrodes are integrated as a single unit with the flexible substrate while the electronics are optimized separately and then hybrid packaged. Constructing the component separately allows for more efficient and cost effective fabrication.

*IP Issue Date
Apr 23, 2013
*IP Publication Date
Nov 26, 2009
*Principal Investigation

Name: Toshikazu Nishida

Department:


Name: John Harris

Department:


Name: Jose Principe

Department:


Name: Justin Sanchez

Department:


Name: Rizwan Bashirullah

Department:

附加资料
Inventor: Benowitz, Larry I.
Priority Number: US6440455B1
IPC Current: C07H0019167 | A61K003152 | A61K003170 | A61K00317042 | A61K00317052 | A61K00317076 | A61K0031708 | A61P002500 | A61P002508 | A61P004300
US Class: 424450 | 424422 | 424423 | 424484 | 424486 | 424489 | 424490 | 424497 | 514045
Assignee Applicant: Children's Medical Center Corporation,Boston
Title: Methods for modulating the axonal outgrowth of central nervous system neurons
Usefulness: Methods for modulating the axonal outgrowth of central nervous system neurons
Summary: To modulate axonal outgrowth of CNS neurons, preferably stimulating or inhibiting the outgrowth. The method is particularly useful for stimulating axonal outgrowth following injury such as that due to stroke, traumatic brain injury, cerebral aneurysm, spinal cord injury (preferably monoplegia, diplegia, paraplegia, hemiplegia and quadriplegia) or for inhibiting axonal outgrowth in CNS neurons in patients suffering or prone to suffering from conditions characterized by increased axonal outgrowth of CNS neurons such as epilepsy, especially posttraumatic epilepsy, neuropathic pain syndrome. The method is useful in mammals, preferably humans, particularly for modulation of growth of CNS retinal ganglion cells.
Novelty: Modulating axonal outgrowth of central nervous system
主要类别
化工/材料
细分类别
化工/材料应用
申请日期
May 22, 2009
申请号码
8,428,732
其他
国家/地区
美国

欲了解更多信息,请点击 这里
移动设备